MSB 1.02% 99.0¢ mesoblast limited

Rheumatoid Arthritis:Estimated Case number in Major...

  1. 4,149 Posts.
    lightbulb Created with Sketch. 5419
    Rheumatoid Arthritis:
    Estimated Case number in Major Markets
    Treatment Costs - 2018 USD
    Global Market Therapy size (2015)
    Average total Treatment cost

    Total number of Yearly cases diagnosed for Rheumatoid Arthritis in 8 Major Markets estimated at 6.5 Million with 18.9 Billion USD spent in 2015 on therapies, USA having approximately 2.8 million cases estimated. Treatment costs ranges from ongoing medication ( $2,000 annually ) or Biologics ( $30,000 annually ) , through to joint replacement surgery $30,000 per procedure on average. Total medical costs were per person on average are estimated at $12,500 for any type of treatment, or $36,500 for use of biologics.


    Market Cost Sizes in USD for 8 major markets:

    18.9 Billion + ( Last Reported 2015 )


    Crohn's Disease:
    Crohns disease numbers

    Estimate that 750,000 US patients per year suffering from Crohns Disease. Average direct medical costs are $18,500 per patient per year, with 25% of sufferers spending closer to $60,000 USD per year.

    Market Cost Sizes in USD for USA, assumed with only more severe sufferers 25% encompassing the refractory target group

    11.2 Billion ( US market only )
    Last edited by dachopper: 07/06/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.